BioMotiv announces new startup: Anti-cancer drug developer Z53 Therapeutics
The company is looking to create drugs that will tackle cancer tumors with p53 protein mutations.
The Harrington Project
The company is looking to create drugs that will tackle cancer tumors with p53 protein mutations.